Nasopharyngeal Cancer

Herr Professor Dr. Michael Molls leitet die Universitätsklinik für Strahlentherapie und radiologische Onkologie am Klinikum rechts der Isar in München.

The Epidemiology of Nasopharyngeal Carcinoma.- Pathogenesis and Etiology of Nasopharyngeal Carcinoma.- Molecular Signaling Pathways in Nasopharyngeal Cancer.- Natural History, Presenting Symptoms, and Diagnosis of Nasopharyngeal Carcinoma.- Screening and Early Diagnosis of Nasopharyngeal Carcinoma.- Familial Nasopharyngeal Carcinoma.- Pathology of Nasopharyngeal Carcinoma.- Imaging in the Diagnosis and Staging of Carcinoma of Nasopharynx.- Prognostic Factors in Nasopharyngeal Cancer.- Early Stage Nasopharyngeal Cancer: A Highly Curative Disease with Radiation Therapy.- Drug Therapy for Nasopharyngeal Carcinoma: Cytotoxic and Targeted Therapy.- The Intergroup 0099 Trial for Nasopharyngeal Cancer: History, Perceptions, and Transitions.- Concurrent Chemotherapy-Enhanced Radiation: Trials and Conclusions.- Neoadjuvant Chemotherapy: Trials and Conclusions.- Adjuvant Chemotherapy for Nasopharyngeal Carcinoma.- Advances in the Technology of Radiation Therapy for Nasopharyngeal Carcinoma.- Selection and Delineation of Target Volumes in Intensity-Modulated Radiation Therapy for Nasopharyngeal Cancer.- Post-treatment Follow-Up of Patients with Nasopharyngeal Cancer.- Management of Patients with Failure Following Definitive Radiation Therapy: Reirradiation in Patients with Locally Recurrent Nasopharyngeal Carcinoma.- Surgery for Recurrent Nasopharyngeal Carcinoma.- Systemic Treatment for Incurable Recurrent and/or Metastatic Nasopharyngeal Carcinoma.- Long-Term Complications in the Treatment of Nasopharyngeal Carcinoma.- Nasopharyngeal Cancer in Pediatric and Adolescent Patients.- Staging of Nasopharyngeal Carcinoma.